Sign in
Username
Password
Lost your password?
Login
Login with Facebook
Login with Google
Login with LinkedIn
(close)
Search for:
Sign in
Register
Country Reports
InFocus
Europe
Asia-Pacific
Americas
Middle East & Africa
Legal & Regulatory
Sign in / Register
Country Reports
Americas
Asia-Pacific
Europe
Middle East & Africa
Vaccines
Legal & Regulatory
Shop
Search for:
Library
Contributions
China
COVID-19
Cell & Gene Therapy
Vaccines
News Releases
Facts & Figures
Directory
Shop
Tagged with Rare Disease
NORD Chief Strategy Officer on Health Equity’s Vital…
With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected patients in the US, the National…
Save
Share
5 US Rare Disease Start-Ups to Watch
Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan therapies in Europe, here we move to…
Save
Share
5 European Rare Disease Start-Ups to Watch
With Rare Disease Day falling on 28 February, PharmaBoardroom dedicates this month to exploring the global rare disease landscape, highlighting key…
Save
Share
Biogen’s Swiss Head on Benefits of Diverse Experience…
A trained physician with several years of practice under her belt, Katharina Gasser then moved into clinical research as an investigator before…
Save
Share
Top 10 Global Rare Disease Companies
The Top 10 rare disease companies globally, ranked by worldwide orphan drug sales for 2018. Celgene takes top spot, followed by Roche and Novartis.…
Save
Share
Ipsen CEO David Loew on M&A, Rare Disease Expansion, Niche…
In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical first 100 days at the helm of the…
Save
Share
Rare Disease Strategies in the Booming US Market
Rare disease – defined in the US as a disease with a maximum patient population of 200,000 – is perhaps the most salient issue at the nexus of…
Save
Share
Pierre Morneau – General Manager, Takeda Switzerland
Pierrre Morneau of Takeda Switzerland explains the therapeutic areas at the core of the company, equitable access, the Swiss framework for rare…
Save
Share
Stephen Farr – President & CEO, Zogenix
Zogenix’s Dr Stephen Farr shares his remarkable career journey from academia to industry, the company’s transition from pain therapeutics into…
Save
Share
Ramona Sequeira – President, Takeda Pharmaceuticals USA;…
Takeda USA’s Ramona Sequeira outlines her expanded role as president of global portfolio commercialization, the crucial importance of investing in…
Save
Share
Bradley Campbell – President & COO, Amicus…
Brad Campbell, president and COO of US rare disease specialist Amicus, talks domestic and global product launches, the company’s first steps into…
Save
Share
Katharina Gasser – Managing Director, Biogen Switzerland…
Biogen Switzerland’s Dr Katharina Gasser outlines how the company’s 100 percent commitment to neuroscience helps it to stand apart, why…
Save
Share
Page: 1 |
1
2
3
4
5
6
7
8
9
10
11
interviews
{"post_type":["article","interviews","legal_article","facts","infocus","sponsored"],"post_status":"publish","posts_per_page":12,"max_num_pages":-1,"paged":1,"meta_query":[{"key":"related","value":"Rare Disease","compare":"LIKE"}]}
We use cookies to ensure that we give you the best experience on our site. For more info
click here
ACCEPT